Wolverine Asset Management’s Ibere Pharmaceuticals IBER Stock Holding History

Wolverine Asset Management’s Portfolio IBER Stock Details IBER Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-28,841	Closed	-$291K	–	2330
2022 Q4	$291K	Buy	+28,841	New	+$289K	﹤0.01%	1067
2021 Q4	–	Sell	-3,051	Closed	-$29K	–	2372
2021 Q3	$29K	Buy	+3,051	New	+$29.5K	﹤0.01%	1551

Wolverine Asset Management's IBER Position: Q1 2023 in Review

Wolverine Asset Management sold out of Ibere Pharmaceuticals (IBER) in Q1 2023, closing a stake of 28,841 shares — an estimated $291K sold.

Wolverine Asset Management first reported a position in IBER in Q3 2021 and held it in 2 quarters. The position peaked at $291K in Q4 2022. 0 funds tracked by Wall St. Rank hold IBER as of Q1 2023.

Wolverine Asset Management reported no remaining Ibere Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
Wolverine Asset Management sold 28,841 Ibere Pharmaceuticals shares in Q1 2023, an estimated $291K.
Wolverine Asset Management first reported a position in Ibere Pharmaceuticals in Q3 2021 and held it in 2 quarters.
Wolverine Asset Management's Ibere Pharmaceuticals position peaked at $291K in Q4 2022.
0 funds tracked by Wall St. Rank held Ibere Pharmaceuticals as of Q1 2023.

Based on Wolverine Asset Management's 13F filing for Q1 2023, filed 8 May 2023.